MARKET INSIGHTS
The Global MOPS (CAS 1132-61-2) market size was valued at USD 148.6 million in 2025. The market is projected to grow from USD 157.9 million in 2026 to USD 271.4 million by 2034, exhibiting a CAGR of 6.2% during the forecast period.
MOPS, chemically known as 3-(N-morpholino)propanesulfonic acid, is a zwitterionic biological buffer widely used in biochemistry and molecular biology applications. It belongs to the family of Good’s buffers, valued for its ability to maintain stable pH levels in the range of 6.5 to 7.9, making it particularly suitable for cell culture, electrophoresis, and enzyme assays. Its low ionic strength interference and minimal toxicity to biological systems have established it as a preferred buffering agent across research and biopharmaceutical manufacturing environments.
The market is witnessing steady growth driven by expanding life sciences research, rising biopharmaceutical production activities, and growing adoption in proteomics and genomics workflows. Furthermore, the increasing number of academic and commercial research laboratories globally continues to sustain demand for high‑purity biological buffers such as MOPS. Key suppliers operating in this space include Sigma‑Aldrich (Merck KGaA), Thermo Fisher Scientific, and Santa Cruz Biotechnology, each offering varied grades and formulations to serve both research and industrial end‑users.
/MOPS (CAS 1132-61-2) Market – View in Detailed Research Report
1. Merck KGaA (MilliporeSigma)
Headquarters: Rahway, New Jersey, USA
Key Offering: High‑purity MOPS (≥99%) for research and biopharma, GMP‑grade formulations.
Merck KGaA, operating through its MilliporeSigma brand, is a global leader in life science reagents. Its MOPS portfolio spans research grade, ultra‑pure, and endotoxin‑tested variants, supporting a wide range of applications from basic research to large‑scale biopharmaceutical manufacturing.
Sustainability & Growth Initiatives: Investment in green chemistry synthesis, carbon‑neutral production facilities, and digital supply chain transparency.
- Carbon‑neutral manufacturing plants in the US and Germany.
- Digital traceability platform for batch certification.
- Partnerships with academic institutions for buffer optimization.
2. Thermo Fisher Scientific
Headquarters: Waltham, Massachusetts, USA
Key Offering: Comprehensive MOPS catalog including research, ultra‑pure, and GMP‑grade grades.
Thermo Fisher Scientific delivers high‑quality MOPS solutions with rigorous quality control, supporting life science research, drug discovery, and biopharmaceutical production worldwide.
Sustainability & Growth Initiatives: Integrated sustainability framework, waste reduction in manufacturing, and renewable energy usage.
- Zero‑waste production lines.
- Renewable energy procurement for manufacturing sites.
- Lifecycle assessment tools for reagent usage.
3. Tokyo Chemical Industry (TCI)
Headquarters: Tokyo, Japan
Key Offering: Research‑grade MOPS with advanced purification technologies.
TCI offers high‑purity MOPS with stringent quality standards, catering to both academic and industrial customers in Asia and beyond.
Sustainability & Growth Initiatives: Eco‑friendly manufacturing processes and regional distribution optimization.
- Eco‑friendly synthesis routes.
- Regional distribution hubs to reduce carbon footprint.
- Collaborations with local research institutes.
4. Spectrum Chemical
Headquarters: San Diego, California, USA
Key Offering: Research‑grade and GMP‑grade MOPS for biopharma.
Spectrum Chemical supplies high‑quality MOPS with comprehensive documentation, supporting global biopharmaceutical development.
Sustainability & Growth Initiatives: Lean manufacturing and energy efficiency.
- Lean production practices.
- Energy‑efficient manufacturing equipment.
- Supplier engagement on sustainability goals.
5. Aladdin Biochemical
Headquarters: Shanghai, China
Key Offering: Cost‑effective research‑grade MOPS.
Aladdin Biochemical provides competitively priced MOPS solutions for academic and industrial laboratories in China and Asia.
Sustainability & Growth Initiatives: Local sourcing and supply chain transparency.
- Local raw material sourcing.
- Transparent supply chain tracking.
- Partnerships with regional universities.
6. Shanghai Macklin
Headquarters: Shanghai, China
Key Offering: Research‑grade and GMP‑grade MOPS.
Shanghai Macklin delivers high‑purity MOPS with full compliance documentation, supporting China’s expanding biopharma sector.
Sustainability & Growth Initiatives: Green manufacturing and waste minimization.
- Green chemistry protocols.
- Waste reduction programs.
- Energy‑saving technologies.
7. Santa Cruz Biotechnology
Headquarters: Dallas, Texas, USA
Key Offering: Research‑grade MOPS with custom formulations.
Santa Cruz Biotechnology offers versatile MOPS solutions tailored to specific research needs, with a strong focus on customer support.
Sustainability & Growth Initiatives: Product lifecycle management and customer education.
- Lifecycle assessment of reagents.
- Customer training programs.
- Recycling initiatives for packaging.
8. Biosynth AG
Headquarters: Uster, Switzerland
Key Offering: Ultra‑pure MOPS for advanced biopharma applications.
Biosynth AG provides high‑purity MOPS with stringent quality controls, targeting the biopharma market in Europe.
Sustainability & Growth Initiatives: Sustainable sourcing and carbon accounting.
- Sustainable raw material sourcing.
- Carbon footprint accounting.
- Collaboration with EU green initiatives.
9. Molekula Group
Headquarters: London, United Kingdom
Key Offering: Research‑grade MOPS with rapid delivery.
Molekula Group offers high‑quality MOPS with fast turnaround times, supporting research labs across Europe.
Sustainability & Growth Initiatives: Efficient logistics and packaging.
- Optimized logistics networks.
- Eco‑friendly packaging solutions.
- Customer‑centric delivery models.
10. Alfa Aesar (now part of Thermo Fisher)
Headquarters: Austin, Texas, USA
Key Offering: Research‑grade MOPS for analytical chemistry.
Alfa Aesar supplies high‑purity MOPS for analytical and research applications, with a focus on precision and reliability.
Sustainability & Growth Initiatives: Precision manufacturing and waste reduction.
- Precision synthesis processes.
- Waste minimization strategies.
- Partnerships with academic labs.
/MOPS (CAS 1132-61-2) Market – View in Detailed Research Report
/MOPS (CAS 1132-61-2) Market – View in Detailed Research Report
Market Outlook 2026–2034
Based on the projected CAGR of 6.2%, the MOPS market is expected to reach USD 271.4 million by 2034. Growth will be driven by expanding biopharmaceutical manufacturing, increasing demand for advanced cell and gene therapy processes, and the rapid development of precision medicine platforms.
Future Trends
- Ultra‑high purity and endotoxin‑tested MOPS for cell and gene therapy manufacturing.
- Integration of MOPS in microfluidics, organ‑on‑chip, and 3D cell culture systems.
- Expansion of MOPS usage in Asia‑Pacific and Latin America as local biopharma capacity grows.
- Adoption of digital supply chain solutions for real‑time quality assurance.
- Increasing emphasis on sustainability and green chemistry in buffer production.
- Top 10 Companies in the Global Dust Control Wetting Agent Market (2026): Market Leaders Powering Dust Suppression - June 25, 2026
- Top 10 Companies in the Southeast Asia Silkworm Cocoon Extract Market (2026): Market Leaders Powering Regional Innovation - June 25, 2026
- Top 10 Companies in the Pressure Vessel Quality (PVQ) Steel Plate Market (2026): Market Leaders Powering Global Growth - June 25, 2026
